Olink Holding AB (publ)
OLK
Rang in Aktien
#4813
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
Aktienkurs
$26.08
Zuletzt synchronisiert: 2024-07-09
Marktkapitalisierung
$3.10B
Veränderung (1 Tag)
0.31%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel Olink Holding AB (publ) (OLK)
Kategorie
Healthcare
Umsatz von Olink Holding AB (publ) (OLK)
Umsatz im Mar 2024 TTM: $171.45M
Laut den aktuellen Finanzberichten von Olink Holding AB (publ) beträgt der derzeitige Umsatz des Unternehmens (TTM) $171.45M. Im Jahr 2022 erzielte das Unternehmen einen Umsatz von $139.85M eine Steigerung gegenüber dem Umsatz im Jahr 2021, der $94.97M betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Olink Holding AB (publ) von 2019 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $171.45M | 0.91% |
| 2023 | $169.91M | 21.49% |
| 2022 | $139.85M | 47.25% |
| 2021 | $94.97M | 75.66% |
| 2020 | $54.07M | 29.68% |
| 2019 | $41.69M | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $46.34B | 26,926.59% |
US
|
|
| $25.11B | 14,544.26% |
US
|
|
| $2.71B | 1,478.97% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 4,199.90% |
US
|
